Pall Corporation creates a biologics manufacturing training centre

| By | Biotechnologies, Pharmaceutical Education

Pall Corporation, a global leader in filtration, separation and purification, has announced the opening of a $2 million Nanyang Polytechnic (NYP) Centre of Excellence in biologics manufacturing featuring various Pall Biotech technologies for practical training and application.

The centre is located in Nanyang Polytechnic (School of Chemical & Life Sciences) in Singapore. Annually, the one-stop, integrated training center will introduce 300 NYP School of Chemical and Life Sciences students to the latest technologies and advances in the industry.

In its debut year, the NYP Centre of Excellence is showcasing single-use technologies, including chromatography column packing and filter integrity testing apparatus supplied by Pall Biotech. Each technology enables more thorough purification of substances in both biopharmaceutical and biologics processes, and helps students see the value of integrity in process.

“Large molecule drugs offer the potential to treat debilitating and life-threatening diseases in ways that were not possible before. Yet, to achieve this, manufacturing processes need to evolve for greater speed, reduced cost, and higher quality outputs,” commented Steve Waters, Vice-President of Biotechnologies, Pall Biotech Asia. “The NYP center will benefit students— and the wider Biotech industry through direct access to the latest technologies.”

The center complements the existing labs located at NYP with 120 training targets for industry professionals to learn the latest technologies as they grow in their careers. NYP also plans to support industry professionals with short industry courses on cell culture, sterilization techniques, and filtration technologies.

SOURCE: pall corporation
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.